Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
Victoria Tserpeli, Dimitra Stergiopoulou, Dora Londra, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 4-4
Open Access | Times Cited: 17

Showing 17 citing articles:

Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma
Chenhao Zhou, Jialei Weng, Chunxiao Liu, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1261-1278
Closed Access | Times Cited: 65
Circulating tumor cells: from new biological insights to clinical practice
Xuyu Gu, Shiyou Wei, Xin Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
Xiaosha Wen, Huijie Pu, Quan Liu, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6025-6025
Open Access | Times Cited: 41
Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review
Simone Karlsson Terp, Malene Pontoppidan Stoico, Karen Dybkær, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control
Kyle Concannon, Benjamin B. Morris, Carl M. Gay, et al.
Molecular Cell (2023) Vol. 83, Iss. 5, pp. 660-680
Open Access | Times Cited: 28
Artificial intelligence-driven integration of multi-omics and radiomics: A new hope for precision cancer diagnosis and prognosis
Jordi Camps, Andrea Jiménez-Franco, Raquel García-Pablo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167841-167841
Closed Access | Times Cited: 1
Blood-based DNA methylation signatures in cancer: A systematic review
Yongzheng Li, Zhiyao Fan, Yufan Meng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1869, Iss. 1, pp. 166583-166583
Open Access | Times Cited: 36
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications
Danielle Benedict Sacdalan, Sami Ul Haq, Benjamin H. Lok
Current Oncology (2024) Vol. 31, Iss. 1, pp. 482-500
Open Access | Times Cited: 7
Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management
Binliang Wang, Meng Wang, Ya Lin, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 11, pp. 2111-2127
Open Access | Times Cited: 7
Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
Lingyu Li, Yingli Sun
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 7
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer
Daniela Scattolin, Alessandro Dal Maso, Alessandra Ferro, et al.
Cancer Treatment Reviews (2024) Vol. 128, pp. 102768-102768
Closed Access | Times Cited: 6
Targeted DNA Demethylation: Vectors, Effectors and Perspectives
Naohiro Yano, Alexey V. Fedulov
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1334-1334
Open Access | Times Cited: 13
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis
Cristina Taliento, Giampaolo Morciano, Camilla Nero, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 6, pp. 906-918
Closed Access | Times Cited: 4
Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation
Yajuan Gao, Nanyang Zhou, J.F. Liu
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 4
Unveiling drug resistance pathways in high-grade serous ovarian cancer(HGSOC): recent advances and future perspectives
Ruiting Fu, Ranliang Hu, Wenting Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Circulating tumor DNA (ctDNA) application in investigation of cancer: Bench to bedside
Hashem O. Alsaab, Mohammad S. Alzahrani, Ammar Abdulraheem Bahauddin, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 758, pp. 110066-110066
Closed Access | Times Cited: 1
Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis
Fang Qiu, Yuntong Li, Lile Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top